| | Author, year | Cases (T/C) | Diagnostic standard | Age (years) | Sex | Dosage | | Range, mean | Male/female | T/C |
| | Ren, 2013 | 32/23 | DCWHO | T: 45~67, 56.2
C: 39~66, 54.8 | 23/9 | T: 10 capsules/time, 3 times/d, oral
C: 30 mg/time, 1 time/d, oral |
| | Liu, 2005 | 33/32 | DCWHO | T: 43~65, 52.3 ± 7.5
C: 41~64, 53.6 ± 8.4 | T: 18/15
C: 19/13 | T: 10 capsules/time, 3 times/d, oral
C: 20 mg/time, 3 times/d, oral |
| | Shi, 2013 | 40/40 | DCWHO | 60~83, 6.75 ± 6.32 | 43/37 | T: 10 capsules/time, 3 times/d, oral
C: 50 mg/time, 1 time/d, oral |
| | Zhang, 2016 | 45/45 | DCWHO | T: 55~83, 64.9 ± 6.2
C: 56~82, 67.3 ± 6.4 | T: 30/15
C: 32/13 | T: 10 capsules/time, 3 times/d, oral
C: 10 mg/time, 3 times/d, oral |
| | Zhang, 2014 | 80/80 | NR | 32~78,65.32 ± 3.10 | 87/73 | T: 10 capsules/time, 3 times/d, oral
C: NR |
| | Jing, 2014 | 84/84 | DCWHO | 62~84,68.8 ± 5.48 | 88/80 | T: 10 capsules/time, 3 times/d, oral
C: 50 mg/time, 1 time/d, oral |
| | Li, 2012 | 60/52 | DCWHO | NR | NR | T: 10 capsules/time, 3 times/d, 5% glucose 250 ml, oral
C: 10 mg/time, 3 times/d, 5% glucose 250 ml, oral |
| | Li, 2016 | 43/42 | NR | T: 61~84, 69.5 ± 5.6
C: 60~83, 69.3 ± 5.4 | T: 26/17
C: 25/17 | T: 10 capsules/time, 3 times/d, oral
C: 50 mg/time, 1 time/d, oral |
| | Yang, 2015 | 32/32 | DCWHO | T: 62~84, 69.4 ± 5.8
C: 60~81, 68.2 ± 5.4 | T: 18/14
C: 19/13 | T: 3 tablets /time, 3 times/d, oral
C: 50 mg/time, 1 time/d, oral |
| | Wang, 2014 | 75/75 | DCWHO | T: 60~82, 68.8 ± 6.5
C: 61~80, 66.7 ± 6.3 | T: 40/35
C: 38/37 | T: 10 capsules/time, 3 times/d, oral
C: 50 mg/time, 1 time/d, oral |
| | Sheng, 2015 | 40/40 | NR | T: 58~80, 65.9 ± 3.6
C: 57~82, 66.8 ± 4.1 | T: 17/23
C: 16/24 | T: 10 capsules/time, 3 times/d, oral
C: 10 mg/time, 3 times/d, oral |
| | Su, 2015 | 106/106 | NR | 58~83, 67.3 ± 6.9 | 127/85 | T: 10 capsules/time, 3 times/d, oral
C: 50 mg/time, 1 time/d, oral |
| | Shao, 2013 | 40/40 | DCWHO | 60~80, 67.75 ± 6.32 | 43/37 | T: 10 capsules/time, 3 times/d, oral
C: 10 mg/time, 3 times/d, oral |
| | Guo, 2013 | 129/107 | DCWHO | 42~70, 51.9 ± 13.6 | 161/75 | T: 10 capsules/time, 3 times/d, oral
C: 20 mg, intravenous drip, 5% glucose 250 ml |
| | Chen, 2009 | 46/46 | ACC/AHA | T: 41~69, 48.5 ± 12.9
C: 45~72, 49.3 ± 11.1 | T: 32/14
C: 31/15 | T: 10 capsules/time, 3 times/d, oral
C: 20 mg/time, 3 times/d, oral |
| | Ma, 2012 | 70/70 | CMACB | 61~78, 67.1 ± 6.4 | 103/37 | T: 10 capsules/time, 3 times/d, oral
C: 30 mg/time, 2 times/d, oral |
| | He, 2011 | 45/45 | DCWHO | T: 66.4
C: 65.7 | T: 25/20
C: 24/21 | T: 10 capsules/time, 3 times/d, oral
C: 30 mg/time, 1 time/d, oral |
| | Zeng, 2014 | 50/50 | DCWHO | 60~76, 67.8 ± 6.5 | 66/34 | T: 10 capsules/time, 3 times/d, oral
C: 20 mg/time, 2 times/d, oral |
| | Geng, 2015 | 63/63 | DCWHO | 44~75, 53.5 ± 7.6 | 65/61 | T: 10 capsules/time, 3 times/d, oral
C: NR |
| | Ma, 2014 | 42/41 | DCWHO | 55~73, 62.5 ± 4.2 | 50/33 | T: 10 capsules/time, 3 times/d, oral
C: 30 mg/time, 1 time/d, oral |
| | Gao, 2013 | 44/44 | DCWHO | T: 52~76, 60.8 ± 7
C: 53~78, 61.5 ± 8 | T: 27/17
C: 29/15 | T: 10 capsules/time, 3 times/d, oral
C: 10 mg/time, oral |
|
|
